The successful execution of the accelerated Vision 2010 program will result in
the continuing evolution of DSM into a specialty life sciences and materials
sciences business. The group will be strongly positioned for growth with the
main drivers being delivered from market-driven innovation and an increasing
presence in the world’s rapidly developing emerging economies, particularly
China, as well as from acquisitions. DSM’s ongoing commitment to Operational
Excellence remains firmly in place.
The adoption of this strategy, with its objective of achieving a better
quality earnings base from higher margin businesses, has enabled DSM to
increase the Vision 2010 targets, as follows:
* for the remainder of the period, based on assumed economic scenario
